Latest News and Press Releases

- Strong Q1 2014 Revenue Growth of 50% Year-over-Year - - Raised 2014 Guidance - GOLETA, Calif., May 13, 2014 (GLOBE NEWSWIRE) -- Inogen, Inc. (Nasdaq:INGN), a medical technology company...

BERKELEY HEIGHTS, N.J., May 13, 2014 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral...

BUFFALO, N.Y., May 13, 2014 (GLOBE NEWSWIRE) -- Synacor Inc. (Nasdaq:SYNC), the leading provider of next-gen start experiences, award-winning TV Everywhere solutions and cloud-based Identity...

BETHESDA, Md., May 13, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...

Gained EPA approval and commercially launched Venerate™ bioinsecticide Completed installation of two 20,000 liter fermentation tanks at our Michigan facility and initiated commercial...

Phase 2 PUMA Study of PROHEMA® in Adult Hematologic Malignancies Enrolling Patients Phase 1b PROMPT Study of PROHEMA in Pediatric Hematologic Malignancies Cleared by FDA IND Submission for...

SAN DIEGO, May 13, 2014 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver...

First Quarter Net Sales Increase 14% to $777 million; Diluted EPS Increases to $1.22 Company Reiterates Full Year Guidance and Provides Second Quarter Guidance RICHARDSON, Texas, May 13, 2014...

NEWARK, Calif., May 13, 2014 (GLOBE NEWSWIRE) -- Revance Therapeutics, Inc. (Nasdaq:RVNC), today reported financial results for the three months ended March 31, 2014. Revance's operating loss for the...

OKLAHOMA CITY, May 13, 2014 (GLOBE NEWSWIRE) -- PostRock Energy Corporation (Nasdaq:PSTR) today announced its results for the quarter ended March 31, 2014. Highlights Revenue totaled $21.8...